Product Description
Specification
- Packaging Size : pfs
- Composition : Filgrastim
- Manufacturer : Reliance Life Sciences
- Treatment : cancer medicine
- Prescription/Non prescription : Prescription
- Brand : religrast
- Dose/Strength : 300 mcg
- Packaging Type : pfs
- Usage/Application : Clinical
How Does Religrast 300 Mcg Injection Work?Religrast 300 Mcg Injection contains Filgrastim, a synthetic form of granulocyte colony stimulating factor. This stimulation prompts the bone marrow to produce more neutrophils, a type of white blood cell vital for fighting infections. The increased neutrophil count helps reduce the risk of infections, particularly in patients undergoing chemotherapy.
Proper Usage and AdministrationReligrast is administered via subcutaneous or intravenous injection under the supervision of a qualified healthcare professional. The dosing and schedule will be determined by your physician, based on your treatment needs. It is essential not to self-inject or adjust the dose without medical consultation to ensure safety and effectiveness.
Storage and Handling PrecautionsTo maintain its efficacy and sterility, Religrast should be stored in a cool, dry place away from light and moisture. Keep it out of reach of children, and never use it beyond the expiry date provided on the packaging. Always check the batch number and expiry before use.
FAQ's of Religrast 300 Mcg Injection:
Q: How should Religrast 300 Mcg Injection be administered?
A: Religrast 300 Mcg Injection should be administered either subcutaneously or intravenously, as directed by a healthcare professional. Patients are advised not to self-administer unless specifically trained by their physician.
Q: What is the main benefit of using Religrast 300 Mcg Injection?
A: The main benefit of Religrast is its ability to stimulate the production of neutrophils in the bone marrow, reducing the risk of infections in individuals with chemotherapy-induced neutropenia.
Q: When is Religrast recommended during treatment?
A: Religrast is typically recommended when a patient undergoing chemotherapy experiences or is at risk for low neutrophil counts. The exact timing and duration are determined by a physician based on treatment response.
Q: Where should Religrast 300 Mcg Injection be stored?
A: The injection should be stored in a cool, dry place, protected from light and moisture, and always kept out of reach of children to preserve sterility and potency.
Q: What precautions should be taken while using Religrast?
A: Religrast should only be used under medical supervision, and patients should never exceed the prescribed dose. Always check the batch number and expiry date. Immediately report any unusual reactions to your doctor.
Q: What are the key ingredients in Religrast 300 Mcg Injection?
A: The injection contains Filgrastim (300 mcg) as the active ingredient, along with water for injection and buffering agents, forming a clear, colorless, and odorless sterile solution.